Table 1 Demographic characteristics in patients with or without cardiovascular events (CVEs)
Variables | Total (n = 1506) | Patients with CVEs (n = 146) | Patients without CVEs (n = 1360) | P value |
|---|---|---|---|---|
Baseline characteristics | ||||
Age (years) | 58.76 ± 10.09 | 58.65 ± 10.04 | 59.90 ± 10.16 | 0.23 |
Male (n,%) | 1099(73%) | 100(68.5%) | 999(73.5%) | 0.20 |
Family history of CAD (n,%) | 204(13.5) | 22(15.1) | 182(13.4) | 0.57 |
Hypertension (n,%) | 971(64.5%) | 108(74%) | 863(63.5%) | 0.01 |
Dyslipidemia (n,%) | 1165(77.4%) | 114(78.1%) | 1051(77.3%) | 0.83 |
Diabetes (n,%) | 431(28.6%) | 55(37.3%) | 376(27.6%) | 0.01 |
Current smoking (n,%) | 786(52.2%) | 66(45.2%) | 720(52.9%) | 0.08 |
BMI (kg/m2) | 25.57 ± 3.16 | 25.58 ± 3.18 | 25.51 ± 2.96 | 0.80 |
Lipid-lowering treatment (n,%) | 630(41.8%) | 54(37.0%) | 576(42.4%) | 0.21 |
Aspirin treatment (n,%) | 1480(98.3%) | 143(97.9%) | 1337(98.3%) | 0.75 |
Laboratory parameters | ||||
TG (mmol/L) | 1.73 ± 1.00 | 1.78 ± 1.17 | 1.73 ± 0.98 | 0.54 |
TC (mmol/L) | 4.14 ± 1.13 | 4.25 ± 1.13 | 4.13 ± 1.13 | 0.22 |
LDL-C (mmol/L) | 2.45 ± 0.89 | 2.53 ± 0.95 | 2.44 ± 0.88 | 0.27 |
HDL-C (mmol/L) | 1.08 ± 0.26 | 1.08 ± 0.28 | 1.08 ± 0.26 | 0.88 |
FFAs (mmol/L) | 0.43 ± 0.19 | 0.47 ± 0.22 | 0.42 ± 0.19 | 0.002 |
HbA1c (%) | 6.41 ± 1.14 | 6.64 ± 1.33 | 6.39 ± 1.12 | 0.03 |
FPG (mmol/L) | 5.62 ± 1.60 | 5.92 ± 1.85 | 5.59 ± 1.57 | 0.04 |
LVEF(%) | 62.53 ± 8.61 | 61.81 ± 9.03 | 62.72 ± 8.54 | 0.07 |
NT-pro-BNP (fmol/ml) | 728.27 ± 532.25 | 763.55 ± 589.38 | 713.71 ± 494.94 | 0.09 |
Creatine (umol/L) | 74.77 ± 15.20 | 76.35 ± 15.98 | 74.50 ± 15.09 | 0.12 |
hs-CRP (mg/L) | 2.88(0.01–17.69) | 3.04(0.01–13.73) | 2.87(0.01–17.69) | 0.12 |
cTnI (ng/ml) | 0.07(0.001–7.37) | 0.08(0.001–2.91) | 0.07(0.001–7.37) | 0.28 |